Health · 1 view
International consensus sets updated framework for CAR T-cell therapy in severe autoimmune diseases
An international multidisciplinary group of 31 experts has updated consensus recommendations to guide the use of CAR T-cell therapy in patients with severe, treatment-refractory autoimmune diseases.
Summary
An international multidisciplinary group of 31 experts has updated consensus recommendations to guide the use of CAR T-cell therapy in patients with severe, treatment-refractory autoimmune diseases. Published in The Lancet Rheumatology , these 2026 recommendations were developed jointly by EBMT, ISCT and JACIE, with contributions from representatives of EULAR and ECTRIMS.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- 'Medicare for All' message attracts midterm voters buckling under medical billsContinue reading
- Abnormal lymph vessels show heightened growth signaling regardless of key gene mutationContinue reading
- Pausing certain arthritis drugs after COVID-19 vaccination raises flare risk without improving antibody responseContinue reading
- CDC funding for HIV prevention shifted from providers to states under TrumpContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow